focus -WSS

focus

author：comprehensive 2025-09-29 22:36:51 - browse：7757

The Food and Drug Administration is poised to tell drug and medical device makers how to better include people of color in the clinical trials that test whether products work and are safe, an agency official said Wednesday. Those guidelines are five months late.

To ensure that drugs work for everyone, they must be tested on a representative sample of people. But researchers have found that many clinical trials exclude the people of color who are often most affected by the diseases that drugs treat.

To help fix that problem, Congress passed a law requiring companies to give the FDA their plans for diversifying clinical trials. As part of that process, the agency was expected to issue guidance by the end of last year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Scientists inch closer to single

focus

WSS

Calls for Trump's election interference trial to be televised part of long debate

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

EQRx, failed developer of low

New safety details link Apellis eye drug to rare cases of blindness

Parkland mass shooting to be reenacted for lawsuit

What to expect as Trump is arraigned on his Jan 6. indictment

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

Peter Hotez and the public health issue of online harassment

EQRx, failed developer of low

Affirmative action in medical school literally saved lives

Lifetime voting ban for felony convictions struck down in Mississippi

Affirmative action in medical school literally saved lives

Slain Parkland victim's father speaks out following reenactment

Hepatitis C has a cure — but many Americans still lack access to it

The high personal cost of affirmative action for Black doctors

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

entertainment

Pharma needs to include young adults in clinical research

What the US credit downgrade means for the economy, your finances

What to expect as Trump is arraigned on his Jan 6. indictment

California Joshua trees severely burned in massive wildfire

Scientists find bacteria from stomach of ancient iceman

Medical schools are missing the mark on artificial intelligence

leisure time

hotspot

focus

leisure time